Regulus Therapeutics - a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
http://www.regulusrx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.8 seconds
16x16
32x32
64x64
128x128
Regulus Therapeutics, LLC.
Regulus Therapeutics
1896 Ru●●●●●●●rd Road
Car●●●bad , California, 92008-7208
UNITED STATES
View this contact
Regulus Therapeutics, LLC.
Regulus Therapeutics
1896 Ru●●●●●●●rd Road
Car●●●bad , California, 92008-7208
UNITED STATES
View this contact
Regulus Therapeutics, LLC.
Regulus Therapeutics
1896 Ru●●●●●●●rd Road
Car●●●bad , California, 92008-7208
UNITED STATES
View this contact
BUY YOUR DOMAIN
17
YEARS
4
MONTHS
16
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
132
SITE IP
67.222.32.150
LOAD TIME
0.797 sec
SCORE
6.2
Regulus Therapeutics – A Leading microRNA Therapeutics Company | Regulus Therapeutics – a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease. | regulusrx.com Reviews
https://regulusrx.com
Regulus Therapeutics - a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
Regulus Therapeutics Inc. - Investor Relations
Skip to primary content. Skip to secondary content. Road to the Clinic. Biology & Pharmacology. 4:00 PM ET on Aug 17, 2015. Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting. RNA therapeutics pipeline entering clinical development, an emerging. RNA biomarkers platform to support its therapeutic programs, and a rich intellectual property estate to retain its leadership in the. RNA field have enabled the formation ...
regulusrx.com
Paul C. Grint, M.D. - Regulus Therapeutics
http://www.regulusrx.com/leadership
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Paul C. Grint, M.D. President and Chief Executive Officer. Senior Vice President of Human Capital. Vice President, Finance and Accounting. Victor Knopov, Ph.D. Vice President, Pharmaceutical Development. Michael Huang, M.D. Vice President, Clinical Development. John Grundy, Ph.D. Vice President, DMPK and Toxicology. Christopher Aker, J.D. Vice President, Legal Affairs.
RG-012 - Regulus Therapeutics
http://www.regulusrx.com/therapeutic-areas/rg-012-targeting-mir-21-for-alport-syndrome
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Regulus is developing RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of miR-21 for the treatment of Alport syndrome. Alport syndrome is a life threatening genetic kidney disease with no approved therapies. In preclinical studies, RG-012 has demonstrated potent inhibition of miR-21. ATHENA Natural History Study an...
Publications - Regulus Therapeutics
http://www.regulusrx.com/publications
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures. Halle, B, et al. Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept. Halle B, et al. Jan;126(1):47-55.: 2016-01-01. Androsavich JR, et al. Jan 29;44(2):e13.: 2016-01-29. The Can...
About microRNAs - Regulus Therapeutics
http://www.regulusrx.com/about-micrornas
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. RNAs are small naturally occurring non-coding RNAs that are 20 to 25 nucleotides in length. In 1993 and since then. RNAs have been identified in almost every species, including humans. They are highly conserved and research has shown that. RNAs function as important regulators of gene expression and play a role in multiple cellular processes. RNAs, 600 of which are co...
Advisors - Regulus Therapeutics
http://www.regulusrx.com/advisors
Biology & Pharmacology. Financials & Filings. Events & Presentations. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. David Baltimore, Ph.D. Professor of biology at the California Institute of Technology, member of the National Academy of Sciences, and the recipient of the 1975 Nobel Prize in Physiology or Medicine. Dr. Baltimore is highly regarded as a pioneer in virology and immunology and current research includes investigating the role of. Markus Stoffel, M.D., Ph.D.
TOTAL PAGES IN THIS WEBSITE
14
Obesity: June 2011
http://obeposition.blogspot.com/2011_06_01_archive.html
Blog, news, companies, Body Mass Index, BMI, weight loss, obese, adjustable gastric lap-band surgery, Weight Management, Nutritional, overweight. Pharmaceuticals Search Engine [selected websites]. VIVUS : Additional Data From QNEXA Clinical Trials. EndoSphere : Patent for Obesity Treatment. Boehringer Ingelheim and Zealand Pharma : licence . Regulus Therapeutics and Alnylam Pharmaceuticals :. New GE Technology Targets Obesity-related Disease. Thursday, June 30, 2011. Prevention of Progression to Diabetes.
Essai Clinique
https://blogdelarechercheclinique.com/tag/essai-clinique
Blog de la recherche clinique. Comment se former, trouver un emploi et pratiquer le métier d'attaché de recherche clinique. Aller au contenu principal. Débutants : Commencez ici. Participer à un essai clinique. Apporteur d’affaires en recherche clinique. Archives du mot-clé essai clinique. Découvre la 2ème édition de l’ebook gratuit de Mosio! Nous avons participé à sa rédaction! Découvre la 2ème édition de l’ebook gratuit de Mosio! Nous avons participé à sa rédaction! Biotech américaine), Bay recruitment.
Vanessa Montanari
https://blogdelarechercheclinique.com/author/admin
Blog de la recherche clinique. Comment se former, trouver un emploi et pratiquer le métier d'attaché de recherche clinique. Aller au contenu principal. Débutants : Commencez ici. Participer à un essai clinique. Apporteur d’affaires en recherche clinique. Archives de l’auteur : Vanessa Montanari. A propos Vanessa Montanari. ARC et TEC à compter du mois d’Août 2016. Je suis Vanessa Montanari, attachée de recherche clinique, chef de projet et dirigeante, depuis 6 ans, de Pharmaspecific, ma propre société de...
entrepreneursandbusiness.weebly.com
Blog Archives - Entrepreneurs and Business
http://entrepreneursandbusiness.weebly.com/entrepreneurs-and-business-blog/archives/07-2014
Entrepreneurs and Business Blog. Growth and Grow with Dave Lavinsky. Overachievers typically have a mindset of constant growth for themselves and for others - and Dave Lavinsky. Is certainly one of these overachievers. Lavinsky has the credentials to support his quest for growth in the professional and personal areas of life for his clients. With his experience in these areas, Lavinsky then went solo. He co-founded Growthink. Identification and pursuit of new opportunities in the marketplace;. Lavinsky a...
Board of Directors - Regulus Therapeutics Inc.
http://ir.regulusrx.com/directors.cfm
Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Stelios Papadopoulos Ph.D. Chairman of the Board, Director. Member of the Audit Committee. Paul C. Grint M.D. David Baltimore Ph.D. Chair of the Nominating and Governance Committee. Member of the Compensation Committee. Mark G. Foletta. Chair of the Audit Committee. Member of the Nominating and Governance Committee. William Rastetter Ph.D. Member of the Audit Committee. Chair of the Compensation Committee.
Investment Calculator - Regulus Therapeutics Inc.
http://ir.regulusrx.com/calculator.cfm
Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Calculate Current Value and Shares Since: October 4, 2012. Oct 4, 2012. There are no adjustments for your investment. Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards.
SEC Filings - Regulus Therapeutics Inc.
http://ir.regulusrx.com/sec.cfm
Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. All Filings (excluding Section 16). Nov 2, 2016. File is in Briefcase. Nov 1, 2016. File is in Briefcase. Oct 7, 2016. Hagan, joseph p. File is in Briefcase. Oct 7, 2016. Grint, paul c. File is in Briefcase. Oct 5, 2016. Wright, timothy michael. File is in Briefcase. Oct 5, 2016. File is in Briefcase. Aug 3, 2016. File is in Briefcase. Aug 2, 2016. File is in Briefcase. Jun 27, 2016. File is in Briefcase.
Ownership Profile - Regulus Therapeutics Inc.
http://ir.regulusrx.com/ownership-profile.cfm
Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Top Holders: Institutional Investor. Fidelity Management and Research Company. Alnylam Pharmaceuticals, Inc. Wellington Management Company, LLP. BlackRock Institutional Trust Company, N.A. The Vanguard Group, Inc. AXA Investment Managers UK Ltd. South Dakota Investment Council. Goldman Sachs and Company, Inc. State Street Global Advisors (US). Dafna Capital Management, LLC. Northern Trust Investments, Inc.
Quarterly Results - Regulus Therapeutics Inc.
http://ir.regulusrx.com/results.cfm
Annual Reports and Proxies. Keeping our RGLS Family Healthy. Compensation and Financial Rewards. Regulus Therapeutics Inc. Third Quarter 2016 Conference Call. Regulus Reports Third Quarter 2016 Financial Results. Regulus Therapeutics Inc. Second Quarter 2016 Conference Call. Regulus Reports Second Quarter 2016 Financial Results. Regulus Reports First Quarter 2016 Financial Results and Recent Highlights. Regulus Therapeutics Inc. First Quarter 2016 Conference Call. Regulus Therapeutics Inc. First Quar...
TOTAL LINKS TO THIS WEBSITE
132
RegulusReign Technologies | Web Developer & Designer
Bug Fix and Maintenance. For Successful Business, Think Globally! When the world is your marketplace, simple website designing plans give you amazing results. A professional and beautiful website design is the result of creative talent and technical expertise. At RegulusReign Technologies, technology meets creativity at its best to produce quality web designs that not only attract, retain and improve user experience, but also generate higher revenues for your site where ideas meet reality!
Home
Renovation and preservation projects are done with care and concern for architectural and structural integrity as well as beauty and function. Ooking to add on a room to your home or office, our designers and space planners are here to help you every step of the way. Each and every one of our construction projects is carefully and professionally designed. From concept to completion, every step of a project is handled by our team. Wantagh NY 11793 us.
Discover Regulus Resources - Regulus Resources Inc.
Home Page Background Photo 01. Home Page Background Photo 01. Added Value Through Continued Discovery. TSX: REG 0.260 0.00 0.00%. Rio Grande, Argentina. Golden Brew, Nevada, U.S.A. Aguas Calientes, Argentina. El Camino, Argentina. La Frontera, Argentina. Fireweed, B.C., Canada. Management Discussion & Analysis. November 10, 2014:. Regulus Announces Closing of Final Tranche of $5 Million Financing. November 4, 2014:. Regulus Announces Closing of First Tranche of $5 Million Financing. October 12, 2014:.
Regulus : Tepelná čerpadla, solární panely a systémy
Heat Pumps from Sweden. With a smart controller. Our offer of Heat Pumps:. Air Source Heat pumps. These Heat Pumps gain energy. From the ambient air even under as. Low temperatures as -22 C. Ground Source Heat Pumps. These Heat Pumps gain energy. From deep bores or from ground loops. Of solar energy transformation to. Thermal one lies between 75 and 85%. For solar panels supplied by Regulus,. With the average annual efficiency. Regulus offers these solar collectors:. Flat plate solar collectors (panels).
Rugulus Rosso
Regulus Therapeutics – A Leading microRNA Therapeutics Company | Regulus Therapeutics – a leading company developing microRNA therapeutics. Medicines that target the pathways of human disease.
Skip to primary content. Skip to secondary content. RG-125 for NASH in patients with type 2 diabetes/pre-diabetes. Biology & Pharmacology. Launched in February 2014, Regulus’ ‘Clinical Map Initiative’ outlines certain corporate goals to advance its micro. RNA therapeutics pipeline over the next several years. ». Regulus to Present at the 2015 Wedbush PacGrow Healthcare Conference ». Regulus Reports Second Quarter 2015 Financial Results and Recent Highlights ». There are no upcoming events.
Regulus Sound Productions
In posuere eleifend odio. Quisque semper augue mattis maecenas ligula. In posuere eleifend odio. Quisque semper augue mattis maecenas ligula. In posuere eleifend odio. Quisque semper augue mattis maecenas ligula. In posuere eleifend odio. Quisque semper augue mattis maecenas ligula. Integer gravida nibh quis urna. Augue praesent a lacus at urna congue rutrum. This is Ex Machina. A responsive HTML5 site template freebie by TEMPLATED. Released for free under the Creative Commons Attribution. Ndash; John Sm...
Regulus Star | ASTRO VEGA BURSA – Vimala Meral Topdemir
ASTRO VEGA BURSA – Vimala Meral Topdemir. Vimala Meral Topdemir – Astroloji Danışmanlığı. Eposta ile Blogu Takip Et. Yeniliklerden ve yazılardan haberdar olmak için lütfen mail adresini yaz. WordPress.com'da ücretsiz bir web sitesi ya da blog oluşturun. WordPress.com'da Blog Oluşturun. Abone Ol “Regulus Star”. Her yeni yazı için posta kutunuza gönderim alın. Diğer 64 takipçiye katılın. WordPress.com ile bir web sitesi oluştur. Add your thoughts here. (optional).
Радиаторы отопления | Медно-алюминиевые радиаторы REGULUS-system, украина
Приглашаем Вас посетить наш новый сайт www.regulus.com.ua. На нашем новом сайте Вы найдете более полную информацию о продукции компании REGULUS-system. С уважением коллектив "Regulus-system Украина". С 1 января 2014 года действует новый прайс-лист на медно-алюминиевые радиаторы компании Regulus-system Украина. Новые прайс-листы можно найти в разделе Прайс-лист. В 2014 ГОДУ КОМПАНИЯ REGULUS-system Украина РЕШИЛА ПРОДОЛЖИТЬ АКЦИЮ. ЦВЕТНОЙ РАДИАТОР ПО ЦЕНЕ БЕЛОГО. АКЦИЯ ЦВЕТНЫЕ РАДИАТОРЫ ПО ЦЕНЕ БЕЛЫХ!
regulustech.com - Registered at Namecheap.com
This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! This domain is registered at Namecheap. This domain was recently registered at Namecheap. Please check back later! The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor the domain owner maintain any relationship with the advertisers.
SOCIAL ENGAGEMENT